ClinicalTrials.Veeva

Menu

Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder

University of California San Francisco (UCSF) logo

University of California San Francisco (UCSF)

Status

Enrolling

Conditions

Alcohol Use Disorder

Treatments

Device: Low Intensity Focused Ultrasound

Study type

Interventional

Funder types

Other

Identifiers

NCT06518785
24-41883

Details and patient eligibility

About

This study aims to examine the effects of Low-Intensity Focused Ultrasound (LIFU) on brain activity in patients with alcohol use disorder.

Full description

This is a single-center, double-blind, controlled, randomized, complete block, 2-period crossover pilot trial. The study will assess target engagement of the ventral striatum after LIFU in patients with alcohol use disorder using resting state and task-based functional magnetic resonance imaging (fMRI).

Enrollment

25 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male or female ≥ 18 years of age.
  2. Documentation of an AUD diagnosis per DSM-5 criteria as evidenced by problematic pattern of alcohol use leading to clinically significant impairment or distress, as manifested by at least two of the DSM-5 criteria, occurring within a 12-month period.
  3. Be willing to undergo a brain MRI and follow study protocol.

Exclusion criteria

  1. Pregnant or breastfeeding.
  2. Presence of a condition or abnormality that would compromise the safety of the patient or the quality of the data.
  3. Non-English speaking.
  4. Other investigational AUD treatments.
  5. Primary psychosis, Bipolar I, or severe personality disorder.
  6. Active suicidality or history of suicide attempt in the past 5 years.
  7. Cognitive impairment (MoCA <24)
  8. Significant medical or neurological disease, or life expectancy <12 mos.
  9. Significant brain abnormality on brain imaging.
  10. Any MRI exclusion criteria.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

25 participants in 2 patient groups

VS LIFU/ VPL LIFU
Experimental group
Description:
Participants will be assigned to receive VS LIFU during the first LIFU treatment session.
Treatment:
Device: Low Intensity Focused Ultrasound
VPL LIFU/VS LIFU
Active Comparator group
Description:
Participants will be assigned to receive VPL LIFU during the first LIFU treatment session.
Treatment:
Device: Low Intensity Focused Ultrasound

Trial contacts and locations

1

Loading...

Central trial contact

Catherine Borror, BS, CCRP; Sierra Brandts, BS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems